Creative Medical Technology Holdings Inc (OTC:CELZ) is publicly traded commercial stage stem cell company focused on Urology, Orthopedics, and Neurology $CELZ
Joined June 2019
- Tweets 34
- Following 287
- Followers 791
- Likes 4
13 Photos and videos
Pinned Tweet
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of Urology, Neurology and Orthopedics.
#OTC #stocks #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool $CELZ
12
14
30
Creative Medical Technology Holdings, Inc. retweeted
22 Oct 2019
Our new website launched this morning. This is the first step in our physician & patient outreach efforts as we aim to provide a non-surgical treatment option for degenerative disc disease and chronic lower back pain.
stemspine.com
#orthopedics #stemcells #backpain
7
7
22
Creative Medical Technology Holdings, Inc. retweeted
18 Oct 2019
"StemSpine® will surely be welcomed by the over 50 million Americans suffering from chronic lower back pain in the U.S. as a drug free alternative."
prnewswire.com/news-releases…
@stemcellnews @StemCellTracker @StemCellMarket @biospace
#mesoblast #backpain #orthopedics #biotech
6
6
18
Creative Medical Technology Holdings, Inc. retweeted
17 Oct 2019
Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast
Full Story: bit.ly/2VQebtX
@StockDayPodcast $CELZ #OTC #OTCMarkets #OTCStocks #CELZ #CEO #stockDayPodcast #Technology #stockdaymedia #Patent
10
14
"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the forefront as we close out the year."
prnewswire.com/news-releases…
#health #biotechnology #womenshealth #stocks #investing #OTC $CELZ
@CaverStem @femcelz
2
8
21
Creative Medical Technology Holdings, Inc. retweeted
2 Oct 2019
CaverStem® is a long lasting and all natural alternative to current treatments for erectile dysfunction.
Find out more about our patented procedure at caverstem.com
#health #ED #sexualhealth #impotence #sex #MensHealth #regenerativemedicine #WednesdayWisdom
4
2
15
Creative Medical Technology Holdings, Inc. retweeted
26 Sep 2019
New article on @EdgeMediaNet talking about CaverStem being a medical breakthrough for the treatment of erectile dysfunction.
edgemedianetwork.com/health_…
#ThursdayMotivation #menshealth #ED #Biotechnology #lgbtq #gay #health #stemcells
4
3
8
We are very excited to announce our partnership with @EdgeMediaNet! Be on the lookout for our @CaverStem contest that begins October 1, with a grand prize of an all-inclusive trip to @EliteHealthHI
in #Honolulu for a free CaverStem® procedure.
finance.yahoo.com/news/creat…
$CELZ
3
9
18
Creative Medical Technology Holdings, Inc. retweeted
10 Sep 2019
Sexual function and cardiovascular disease: what the general cardiologist needs to know.
heart.bmj.com/content/105/2/…
@mbmd17 @GershmanMDLA @DoctorAmitPatel @PeterNiemczyk @antoniniurology @EliteHealthHI @VictorLiuMDFACS @CMTH_Inc @CaverStem
4
8
As noted in our PR this week, our CaverStem® clinical trial information has been updated to reflect the addition of the 100 patient clinical registry.
clinicaltrials.gov/ct2/show/…
#OTC #stocks #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool $CELZ
1
6
20
CELZ Board of Directors Member, Dr. Amit Patel, discussing the significance of the completion of the CaverStem® clinical trial report when looking at the progression from initial research in 2013 through its' first phase of commercialization.
#OTC #stocks #biotechnology $CELZ
1
9
25
"In the submitted paper, a total of 40 patients were treated in the primary trial and 100 in the clinical registry. This signifies one of the largest clinical studies of a non-drug treatment for erectile dysfunction."
prnewswire.com/news-releases…
#OTC #investing #biotechnology $CELZ
We are pleased to announce the completion of the data analysis and submission of a research paper describing a total of 140 patients treated with the CaverStem® procedure.
prnewswire.com/news-releases……
#OTC #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool $CELZ
2
8
27
We are pleased to announce the completion of the data analysis and submission of a research paper describing a total of 140 patients treated with the CaverStem® procedure.
prnewswire.com/news-releases……
#OTC #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool $CELZ
3
25
We've been working not only on expanding the reach of our patented CaverStem® procedure, but we've also been (and will continue to be) vigilant in protecting our IP against various forms of infringement.
#OTC #investing #Biotechnology #seekingalpha #NYSE #motleyfool $CELZ
4
15
As we emerge from our initial stages of commercialization we are streamlining our communication and web based platforms to improve information sharing with our patients, providers, and shareholders.
#OTC #stocks #biotechnology #seekingalpha #motleyfool $CELZ @CaverStem @FemCelz
1
10
21
"Using cells as drugs represents a more viable alternative to existing approaches because the stem cells not only reduce inflammation, but also have ability to induce healing of injured tissue." - Dr. Ichim, CELZ CSO
#biotechnology #neurology #oncology #motleyfool $CELZ
2
6
25
We're actively engaged in expanding our provider network to find and integrate clinics that are great fits for multiple CELZ patented procedures.
#OTC #stocks #investing #biotechnology #trading #seekingalpha #menshealth #WomensHealth #NYSE #motleyfool $CELZ @CaverStem @FemCelz
4
9
In an effort to increase transparency with our shareholders, we hope this chart will help clarify our corporate structure and how our business is organized with the goal of maximizing shareholder returns.
#OTC #stocks #investing #biotechnology #trading #seekingalpha #NYSE $CELZ
2
8
24
This chart shows CELZ's structure and the strategic operational deployment of our IP portfolio. We are much more than an urology focused biotechnology company. Our IP has broad scope, and we have set up the following entities to deploy our operational strategy.
2
1
6
This structure offers many advantages from a business protection standpoint as well as allowing us to rapidly deploy technologies into new business units in the future.
1
2
9
Come visit our new corporate website showcasing the full breadth of our robust IP/product portfolio.
creativemedicaltechnology.co…
$CELZ @caverstem @FemCelz #OTC #stocks #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool #regenerativemedicine
2
6
17